Erratum: Bionano Interactions of MCF-7 Breast Tumor Cells with a Transferrin Receptor Targeted Nanoparticle (Mol. Pharmaceutics (2015) 12: 5 (1467-1476) DOI: 10.1021/mp500796d);Bionano interactions of MCF-7 breast tumor cells with a transferrin receptor targeted nanoparticle

Molecular Pharmaceutics

Volumn 12, Issue 5, 2015, Pages 1467-1476

  Du, Wenwen ^a,c   Fan, Yuchen ^a   He, Bing ^a   Zheng, Nan ^a   Yuan, Lan ^b   Dai, Wenbing ^a   Zhang, Hua ^a   Wang, Xueqing ^a   Wang, Jiancheng ^a   Zhang, Xuan ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

7peptide; MCF 7 cells; receptor saturation; targeted delivery; transferrin receptor

Indexed keywords

ALANINE; ARGININE; HISTIDINE; ISOLEUCINE; NANOPARTICLE; PROLINE; TRANSFERRIN RECEPTOR; TYROSINE; MICELLE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIONANO INTERACTION; BREAST TUMOR; CANCER THERAPY; CELL MEMBRANE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; EX VIVO STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYSOSOME; MCF 7 CELL LINE; MICELLE; MOUSE; NANOBIOTECHNOLOGY; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; CHEMISTRY; HUMAN; METABOLISM; PROCEDURES;

CELL MEMBRANE; DRUG DELIVERY SYSTEMS; HUMANS; MCF-7 CELLS; MICELLES; NANOMEDICINE; NANOPARTICLES; PEPTIDES; RECEPTORS, TRANSFERRIN;

EID: 84929190337     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.1c00201     Document Type: Erratum

References (45)

1. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2007, 2 (12) 751-760
2. Qian, Z. M.; Li, H.; Sun, H.; Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway Pharmacol. Rev. 2002, 54 (4) 561-587
3. Daniels, T. R.; Delgado, T.; Helguera, G.; Penichet, M. L. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells Clin. Immunol. 2006, 121 (2) 159-176
4. Daniels, T. R.; Bernabeu, E.; Rodriguez, J. A.; Patel, S.; Kozman, M.; Chiappetta, D. A.; Holler, E.; Ljubimova, J. Y.; Helguera, G.; Penichet, M. L. The transferrin receptor and the targeted delivery of therapeutic agents against cancer Biochim. Biophys. Acta 2012, 1820 (3) 291-317
5. Li, Y.; He, H.; Jia, X.; Lu, W. L.; Lou, J.; Wei, Y. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas Biomaterials 2012, 33 (15) 3899-3908
6. van der Meel, R.; Vehmeijer, L. J.; Kok, R. J.; Storm, G.; van Gaal, E. V. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Delivery Rev. 2013, 65 (10) 1284-1298
7. Lu, Q.; Teng, G. J.; Zhang, Y.; Niu, H. Z.; Zhu, G. Y.; An, Y. L.; Yu, H.; Li, G. Z.; Qiu, D. H.; Wu, C. G. Enhancement of p53 gene transfer efficiency in hepatic tumor mediated by transferrin receptor through trans-arterial delivery Cancer Biol. Ther. 2008, 7 (2) 218-224
8. Habashy, H. O.; Powe, D. G.; Staka, C. M.; Rakha, E. A.; Ball, G.; Green, A. R.; Aleskandarany, M.; Paish, E. C.; Douglas Macmillan, R.; Nicholson, R. I.; Ellis, I. O.; Gee, J. M. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen Breast Cancer Res. Treat. 2010, 119 (2) 283-293
9. Daniels, T. R.; Delgado, T.; Rodriguez, J. A.; Helguera, G.; Penichet, M. L. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer Clin. Immunol. 2006, 121 (2) 144-158
10. Navaroli, D. M.; Bellve, K. D.; Standley, C.; Lifshitz, L. M.; Cardia, J.; Lambright, D.; Leonard, D.; Fogarty, K. E.; Corvera, S. Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (8) E471-480
11. Choe, U. J.; Rodriguez, A. R.; Lee, B. S.; Knowles, S. M.; Wu, A. M.; Deming, T. J.; Kamei, D. T. Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles Biomacromolecules 2013, 14 (5) 1458-1464
12. van Dam, E. M.; Stoorvogel, W. Dynamin-dependent transferrin receptor recycling by endosome-derived clathrin-coated vesicles Mol. Biol. Cell 2002, 13 (1) 169-182
13. Bareford, L. M.; Swaan, P. W. Endocytic mechanisms for targeted drug delivery Adv. Drug Delivery Rev. 2007, 59 (8) 748-758
14. Choi, C. H.; Alabi, C. A.; Webster, P.; Davis, M. E. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (3) 1235-1240
15. Lee, J. H.; Engler, J. A.; Collawn, J. F.; Moore, B. A. Receptor mediated uptake of peptides that bind the human transferrin receptor Eur. J. Biochem. 2001, 268 (7) 2004-2012
16. Du, W.; Fan, Y.; Zheng, N.; He, B.; Yuan, L.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery Biomaterials 2013, 34 (3) 794-806
17. Oh, S.; Kim, B. J.; Singh, N. P.; Lai, H.; Sasaki, T. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide Cancer Lett. 2009, 274 (1) 33-39
18. Han, L.; Huang, R.; Liu, S.; Huang, S.; Jiang, C. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors Mol. Pharmaceutics 2010, 7 (6) 2156-2165
19. Han, L.; Huang, R.; Li, J.; Liu, S.; Huang, S.; Jiang, C. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer Biomaterials 2011, 32 (4) 1242-1252
20. Zheng, N.; Dai, W.; Du, W.; Zhang, H.; Lei, L.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Gao, J.; Zhang, Q. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors Mol. Pharmaceutics 2012, 9 (5) 1175-1188
21. He, B.; Lin, P.; Jia, Z.; Du, W.; Qu, W.; Yuan, L.; Dai, W.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells Biomaterials 2013, 34 (25) 6082-6098
22. Kremer, J. J.; Pallitto, M. M.; Sklansky, D. J.; Murphy, R. M. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes Biochemistry 2000, 39 (33) 10309-10318
23. Wang, X.; Chen, X.; Tang, Z.; Yao, W.; Liu, X.; Wei, R.; Wang, X.; Ka, W.; Sun, D.; He, D.; Wen, Z.; Chien, S. Ryanodine receptor 1 mediates Ca2+ transport and influences the biomechanical properties in RBCs J. Biomech. 2009, 42 (16) 2774-2779
24. Fan, Y.; Du, W.; He, B.; Fu, F.; Yuan, L.; Wu, H.; Dai, W.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin Biomaterials 2013, 34 (9) 2277-2288
25. Yao, H. J.; Ju, R. J.; Wang, X. X.; Zhang, Y.; Li, R. J.; Yu, Y.; Zhang, L.; Lu, W. L. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery Biomaterials 2011, 32 (12) 3285-3302
26. Indira Chandran, V.; Matesic, L.; Locke, J. M.; Skropeta, D.; Ranson, M.; Vine, K. L. Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor Cancer Lett. 2012, 316 (2) 151-156
27. Xiang, Y.; Liang, L.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes J. Controlled Release 2011, 152 (3) 402-410
28. Schadlich, A.; Rose, C.; Kuntsche, J.; Caysa, H.; Mueller, T.; Gopferich, A.; Mader, K. How stealthy are PEG-PLA nanoparticles? An NIR in vivo study combined with detailed size measurements Pharm. Res. 2011, 28 (8) 1995-2007
29. Mulik, R. S.; Monkkonen, J.; Juvonen, R. O.; Mahadik, K. R.; Paradkar, A. R. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis Int. J. Pharm. 2010, 398 (1-2) 190-203
30. Zhang, P.; Hu, L.; Yin, Q.; Zhang, Z.; Feng, L.; Li, Y. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation J. Controlled Release 2012, 159 (3) 429-434
31. Golla, K.; Bhaskar, C.; Ahmed, F.; Kondapi, A. K. A target-specific oral formulation of doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer J. Cancer 2013, 4 (8) 644-652
32. Shen, J.; Zhan, C.; Xie, C.; Meng, Q.; Gu, B.; Li, C.; Zhang, Y.; Lu, W. Poly(ethylene glycol)-block-poly(D,L-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery J. Drug Target. 2011, 19 (3) 197-203
33. Bhattacharyya, S.; Bhattacharya, R.; Curley, S.; McNiven, M. A.; Mukherjee, P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (33) 14541-14546
34. Fowler, R.; Vllasaliu, D.; Trillo, F. F.; Garnett, M.; Alexander, C.; Horsley, H.; Smith, B.; Whitcombe, I.; Eaton, M.; Stolnik, S. Nanoparticle transport in epithelial cells: pathway switching through bioconjugation Small 2013, 9 (19) 3282-3294
35. Xu, S.; Olenyuk, B. Z.; Okamoto, C. T.; Hamm-Alvarez, S. F. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances Adv. Drug Delivery Rev. 2013, 65 (1) 121-138
36. Kim, I.; Xu, W.; Reed, J. C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities Nat. Rev. Drug Discovery 2008, 7 (12) 1013-1030
37. Wang, J.; Fang, X.; Liang, W. Pegylated phospholipid micelles induce endoplasmic reticulum-dependent apoptosis of cancer cells but not normal cells ACS Nano 2012, 6 (6) 5018-5030
38. Roiter, Y.; Ornatska, M.; Rammohan, A. R.; Balakrishnan, J.; Heine, D. R.; Minko, S. Interaction of nanoparticles with lipid membrane Nano Lett. 2008, 8 (3) 941-944
39. He, B.; Jia, Z.; Du, W.; Yu, C.; Fan, Y.; Dai, W.; Yuan, L.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. The transport pathways of polymer nanoparticles in MDCK epithelial cells Biomaterials 2013, 34 (17) 4309-4326
40. Goda, T.; Goto, Y.; Ishihara, K. Cell-penetrating macromolecules: direct penetration of amphipathic phospholipid polymers across plasma membrane of living cells Biomaterials 2010, 31 (8) 2380-2387
41. Niebylski, C. D.; Petty, H. R. Cyclosporine A induces an early and transient rigidification of lymphocyte membranes J. Leukoc. Biol. 1991, 49 (4) 407-415
42. Chin, J. H.; Goldstein, D. B. Drug tolerance in biomembranes: a spin label study of the effects of ethanol Science 1977, 196 (4290) 684-685
43. Maruyama, K.; Takizawa, T.; Yuda, T.; Kennel, S. J.; Huang, L.; Iwatsuru, M. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies Biochim. Biophys. Acta 1995, 1234 (1) 74-80
44. Woodle, M. C.; Lasic, D. D. Sterically stabilized liposomes Biochim. Biophys. Acta 1992, 1113 (2) 171-199
45. Owens, D. E., 3rd; Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 2006, 307 (1) 93-102